Form D · Other
82 Labs, Inc.
Los Angeles, CA · CIK 0001737298
Offering snapshot reported Nov 8, 2021 · SEC filing
- Reported sold
- $7.01M Offering amount: $12M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 8, 2021 | Initial | $7,008,028 | No comparison | 16 | SEC filing |
| Apr 16, 2018 | Initial | $9,534,979 | No comparison | 50 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420312
Source: Form D, filed Nov 8, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Josh Groff | Director, Executive |
| Sisun Lee | Director |
| Kenny Leung | Director |
| Hodong Nam | Director |
Issuer details
Industry: Other (See others in industry)
Address:
3435 Wilshire Boulevard, 14th Floor
Los Angeles, CA, 90010
Los Angeles, CA, 90010